Keyphrases
Mephedrone
89%
Synthetic Cannabinoids
85%
Cannabis
80%
Nicotine
64%
Biological Matrices
61%
Synthetic Cathinones
60%
Intoxication
59%
New Psychoactive Substances
59%
Drugs of Abuse
57%
Pharmacological Effects
57%
Intranasal
57%
Prenatal Life
57%
Cotinine
45%
Pediatric
45%
Exposure to Environmental Tobacco Smoke
45%
Alcohol
45%
Pharmacokinetics
45%
Cannabinoids
42%
Oral Fluid
42%
Antidepressants
38%
Cocaine
35%
Amphetamine
34%
Pharmacodynamics
32%
Psychostimulants
32%
New Synthetic Opioids
28%
Fetal Marker
28%
Methamphetamine
28%
Europe
28%
Therapeutic Drug Monitoring
28%
Ethanol Intake
28%
Clinical Evidence
28%
Pregnant Women
28%
Drug Interactions
28%
Cannabidiol
28%
Clinical Pharmacology
28%
Maternal-fetal
28%
COVID-19
28%
Emerging Drugs
28%
Non-oxidative
28%
Ethanol
28%
Environmental Tobacco Exposure
28%
Hair Analysis
28%
Preschool children
28%
Mediterranean City
28%
Acetaldehyde
28%
Opioids
28%
Fentanyl Analogs
28%
Neuropsychiatric
28%
Therapeutic Use
28%
Neuropsychiatric Adverse Events
28%
Pharmacology, Toxicology and Pharmaceutical Science
Mephedrone
100%
Cannabinoid
85%
Observational Study
63%
Cathinone
62%
MDMA
61%
Opiate
57%
Cotinine
57%
Cannabis
56%
Toxic Injury
50%
Pharmacokinetics
48%
Antidepressant
46%
Pharmacodynamics
44%
Biological Marker
43%
Prenatal Exposure
43%
Amphetamine Derivative
36%
Psychostimulant
35%
Ethanol
31%
Antidepressant
28%
Hair Analysis
28%
Psychotropic Agent
28%
Therapeutic Drug Monitoring
28%
Drug Interaction
28%
Adrenergic Receptor Stimulating Agent
28%
Clinical Pharmacology
28%
Fatality
24%
Cannabidiol
22%
Drug Market
21%
Illicit Drug
19%
Tetrahydrocannabinol
17%
Phenethylamine Derivative
16%
Long Term Exposure
15%
Prevalence
14%
Benzoylecgonine
14%
Phencyclidine
14%
Intranasal Route
14%
Mydriasis
14%
Tryptamine Derivative
14%
Ketamine
14%
Piperazine Derivative
14%
Clinical Trial
12%
Infection
12%
Disease
12%
Pharmacotherapy
11%
Isoenzyme
11%
CYP3A4
11%
Fentanyl Derivative
10%
Typical Antipsychotic
9%
Drug-Drug Interaction
9%
Therapeutic Use
7%
Ethyl Sulfate
7%